MediFind found 16526 doctor with experience in Chromophobe Renal Cell Carcinoma. Of these, 12759 are Experienced, 2783 are Advanced, 956 are Distinguished and 28 are Elite.
Loyola University Medical Center
Gopal Gupta is an Urologist in Melrose Park, Illinois. Dr. Gupta is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Prostate Cancer, Nephrectomy, and Cystectomy. Dr. Gupta is currently accepting new patients.
Duke Cancer Center Genitourinary (GU) Clinic
Daniel George is an Urologist and a Hematologist in Durham, North Carolina. Dr. George is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Nephrectomy, and Orchiectomy. Dr. George is currently accepting new patients.
Skip Viragh Outpatient Cancer Center
Dr. Michael A. Carducci is the AEGON Professor in Prostate Cancer Research at the Johns Hopkins University School of Medicine. He serves as the Vice Chair of Solid Tumor Oncology in the Department of Oncology. Dr. Carducci has an expertise in various types of cancer including prostate, kidney, and testicular. He also has an expertise in clinical trials, pain and palliative care for oncology, urological oncology, urology and medical oncology. A graduate of Georgetown University, Dr. Carducci received his medical degree with high distinction from Wayne State University School of Medicine. He completed an internal medicine internship, residency and chief residency at the University of Colorado Health Sciences Center. He went on to complete medical oncology and research fellowships at the Johns Hopkins Oncology Center at Johns Hopkins Hospital. He was promoted to Professor of Oncology and Urology in 2008 and installed into the inaugural AEGON Professorship in Prostate Cancer Research in 2009. He served as Co-Director of the GU Oncology program until 2013. In 2013, he assumed the leadership role of Associate Director for Clinical Research until being named Vice-Chair of Solid Tumor Oncology in 2024. A fellow of the American College of Physicians and a fellow of the American Society of Clinical Oncology, Dr. Carducci has received peer-reviewed funding for his clinical research from the National Cancer Institute, Department of Defense, and the Prostate Cancer Foundation. Mentorship of students, fellows, and junior faculty has been another focus of Dr. Carducci’s career in medicine, receiving numerous teaching awards. Dr. Carducci received the Michaele Christian Award and Lectureship for Oncology Drug Development at the National Cancer Institute in 2011. He chaired the Genitourinary Oncology Committee of ECOG-ACRIN from 2011-2024. In this role, he served on the GU Steering Committee for the NCI. Dr. Carducci is a member of the Investigational Drug Steering Committee for the NCI, and chaired that Committee for four years. He served as Associate Editor for GU Cancers for the Journal of Clinical Oncology from 2013-2024. Overall, his clinical research focus is on the development and evaluation of new therapies for urologic cancers. Incorporation of pharmacodynamics, novel biomarkers, and targeted imaging has been key elements of many of the trials led by Dr. Carducci. To complete these studies, Dr. Carducci facilitates and brings together a multidisciplinary team from urologists, radiation oncologists, pathologists, biostatisticians, and medical oncologists. Other areas of interest include palliative and end of life care, survivorship, and use of patient reported outcomes in clinical research and care. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Carducci is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Hormone Replacement Therapy (HRT), and Orchiectomy.
Loyola University Medical Center
Joseph Clark is a Hematologist Oncology specialist and a Hematologist in Maywood, Illinois. Dr. Clark is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Melanoma, Renal Cell Carcinoma (RCC), Nasopharyngeal Carcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Clark is currently accepting new patients.
Aurora Urology
Mark Waples is an Urologist in Milwaukee, Wisconsin. Dr. Waples is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Ureterocele, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, Nephrectomy, and Reconstructive Urology Surgery.
Duke Cancer Center
Michael Harrison is an Oncologist and a Hematologist in Durham, North Carolina. Dr. Harrison is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, Clear Cell Sarcoma, and Prostatectomy. Dr. Harrison is currently accepting new patients.
Duke Cancer Center Genitourinary (GU) Clinic
Andrew Armstrong is an Oncologist in Durham, North Carolina. Dr. Armstrong is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. Dr. Armstrong is currently accepting new patients.
Advocate Lutheran General Cancer Institute
Timothy Lestingi is a Hematologist and an Oncologist in Park Ridge, Illinois. Dr. Lestingi is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Prostate Cancer, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Ureteroscopy, and Gastrostomy.
Advocate Infusion Center
Jerry Liu is a Hematologist and an Oncologist in Crystal Lake, Illinois. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, Anemia, and Bone Marrow Aspiration.
Dana-Farber Cancer Institute, Inc.
Toni Choueiri is an Oncologist in Milford, Massachusetts. Dr. Choueiri is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Choueiri is currently accepting new patients.
Mskcc Surgery Group
Paul Russo is an Urologist in New York, New York. Dr. Russo is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Reconstructive Urology Surgery.
Brigham And Womens Physicians Organization Inc
Elizabeth Henske is an Oncologist and a Pulmonary Medicine provider in Boston, Massachusetts. Dr. Henske is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. Her top areas of expertise are Lymphangioleiomyomatosis, Chromophobe Renal Cell Carcinoma, Birt-Hogg-Dube Syndrome, and Renal Cell Carcinoma (RCC). Dr. Henske is currently accepting new patients.
Ondrej Hes practices in Pilsen, Czech Republic. Mr. Hes is rated as an Elite expert by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), Nephrectomy, and Penectomy.
St. Luke's Hospital Of Duluth
Robert Thompson is an Urologist in Duluth, Minnesota. Dr. Thompson is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Bladder Cancer, Nephrectomy, and Cystectomy. Dr. Thompson is currently accepting new patients.
Memorial Solid Tumor Group
Martin Voss is an Oncologist in New York, New York. Dr. Voss is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Nephrectomy.
University Of Texas Southwestern Medical Center At Dallas
Hans Hammers is an Oncologist in Dallas, Texas. Dr. Hammers is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Thrombectomy.
Icahn School Of Medicine At Mount Sinai
Ketan Badani is an Urologist in Long Island City, New York. Dr. Badani is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostate Cancer, Nephrectomy, and Prostatectomy.
The Regents Of The University Of California
Allan Pantuck is an Urologist and a Surgical Oncologist in Los Angeles, California. Dr. Pantuck is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostate Cancer, Nephrectomy, and Prostatectomy.
Temple Faculty Practice Plan Inc
Robert Uzzo is an Urologist in Philadelphia, Pennsylvania. Dr. Uzzo is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Renal Oncocytoma, Nephrectomy, and Cystectomy.
Mskcc Surgery Group
Jonathan Coleman is an Urologist in New York, New York. Dr. Coleman is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Prostatectomy.
Last Updated: 01/09/2026








